Skip to main content
. Author manuscript; available in PMC: 2017 Jan 9.
Published in final edited form as: Immunity. 2016 Jul 19;45(1):74–82. doi: 10.1016/j.immuni.2016.06.024

Figure 3. Ly49D Suppresses Activation and Cell-Cycle Progression of B10.D2 Ly49H+ NK Cells at the Peak of NK Cell Response after MCMV Infection.

Figure 3

B6 mice were infected with 1 × 104 pfu MCMV. B10.D2 mice were depleted of CD8+ T cells on the day before infection and then infected with 5 × 104 pfu MCMV.

(A) An activation and differentiation marker Ly6C on Ly49H+ NK cell subsets expressing Ly49D and or Ly49A in the spleen on day 7 pi. Data are representative of four experiments (n = 3–4 in each experiment).

(B) Fold change of percentages of Ly6C+Ly49H+ NK cells was quantified. Data were pooled from two experiments (n = 7 mice in each group).

(C) Ki67 expression by Ly49H+ NK cell subsets expressing Ly49D and or Ly49A in the spleen on day 7 pi. Data are representative of two experiments (n = 3 or 4 in each experiment).

(D) Percentages of Ki67+Ly49H+ NK cells were quantified. Data were pooled from two experiments (n = 7 mice in each group). Bold and thin lines represent Ly49H+ NK cells in infected mice and Ly49H+ NK cells in uninfected mice, respectively.

*p < 0.005. Error bars show SEM.